{"lastClose": 6.679999828338623, "len": 1097, "date": "2023-02-21", "alpha_1": -0.16198100013466188, "beta_1": 1.6625614047863424, "drawup_1": 1.5486725887776869, "natr_1": 13.132006973635379, "sup_1": -0.6007983929350051, "res_1": 0.36427152355305564, "bullPattern_1": [], "bearPattern_1": ["SHORTLINE"], "rsi_1": 55.656696573679895, "adx_1": 31.202718339745452, "drawdown_1": -0.674768538064794, "stratHoldSharpe_1": -0.06958626985836631, "stratHoldAlpha_1": 250.95131194915038, "stratHoldDrawdown_1": -0.6366945950351088, "alpha_3mo": -0.6122636951072383, "beta_3mo": 2.1070152714470387, "drawup_3mo": 0.4608541290620036, "natr_3mo": 13.132006973635379, "sup_3mo": -0.043912158693504136, "res_3mo": 0.10978043242516558, "bullPattern_3mo": [], "bearPattern_3mo": ["LONGLINE"], "rsi_3mo": 34.04907679332498, "adx_3mo": 35.77534908870677, "drawdown_3mo": -0.4781801627958294, "stratHoldSharpe_3mo": -2.405756076537747, "stratHoldAlpha_3mo": 249.474094426928, "stratHoldDrawdown_3mo": -0.4310425296156527, "Market Cap": 959718575, "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "IPO Year": 2018.0, "Country": "United States", "Name": "Allogene Therapeutics Inc.", "Sector": "Health Care", "alpha%_1": 0.39182560062001165, "beta%_1": 0.9096781681255612, "drawup%_1": 0.9973314788954531, "natr%_1": 0.9999260636024501, "drawdown%_1": 0.06593733869464845, "stratHoldSharpe%_1": 0.39517992851923633, "stratHoldAlpha%_1": 0.360748152792086, "stratHoldDrawdown%_1": 0.053128858229895645, "alpha%_3mo": 0.09535179385112785, "beta%_3mo": 0.9764185451400019, "drawup%_3mo": 0.8880241110960022, "natr%_3mo": 0.9998919129339743, "drawdown%_3mo": 3.0170451100926366e-05, "stratHoldSharpe%_3mo": 0.029493703900183802, "stratHoldAlpha%_3mo": 0.0005391515593420526, "stratHoldDrawdown%_3mo": 3.8239249220554707e-05}